| KOTAK NIFTY ALPHA 50 ETF
An open ended scheme replicating / tracking NIFTY Alpha 50 Index
NSE Symbol - ALPHA
| KOTAK NIFTY ALPHA 50 ETF
An open ended scheme replicating / tracking NIFTY Alpha 50 Index
NSE Symbol - ALPHA

   

   
Investment Objective
The investment objective of the scheme is to replicate the composition of the NIFTY Alpha 50 Index and to generate returns that are commensurate with the performance of the NIFTY Alpha 50 Index, subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
The investment objective of the scheme is to replicate the composition of the NIFTY Alpha 50 Index and to generate returns that are commensurate with the performance of the NIFTY Alpha 50 Index, subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
Issuer/Instrument
% to Net
Assets

Equity & Equity related
Finance 25.62
L&T FINANCE HOLDINGS LTD 4.63
Muthoot Finance Ltd 4.28
Aditya Birla Capital Ltd. 3.55
Manappuram Finance Ltd 3.32
BAJAJ FINANCE LTD. 2.43
SHRIRAM FINANCE LTD. 1.78
Cholamandalam Investment and Finance Company Ltd. 1.67
IIFL Finance Ltd 1.36
Bajaj Finserv Ltd. 1.31
POONAWALLA FINCORP LTD. 1.27
Bajaj Holdings and Investment Ltd. 0.02
Banks 13.85
RBL Bank Ltd 4.27
AU Small Finance Bank Ltd. 2.99
INDIAN BANK 2.77
CANARA BANK 2.16
BANK OF INDIA 1.66
Capital Markets 7.81
BSE LTD. 3.83
MULTI COMMODITY EXCHANGE OF INDIA LIMITED 3.03
HDFC Asset Management Company Ltd. 0.95
Electrical Equipment 6.91
HITACHI ENERGY INDIA LIMITED 3.87
GE VERNOVA T&D INDIA LIMITED 3.04
Automobiles 6.78
Eicher Motors Ltd. 2.03
TVS Motors Company Ltd 2.01
Maruti Suzuki India Limited 1.79
Mahindra & Mahindra Ltd. 0.95
Healthcare Services 4.65
Narayana Hrudayalaya Ltd. 2.39
Fortis Healthcare India Ltd 1.71
MAX HEALTHCARE INSTITUTE LTD. 0.55
Insurance 4.46
Max Financial Services Ltd. 2.28
SBI Life Insurance Company Ltd 1.66
HDFC Life Insurance Company Ltd. 0.52
Pharmaceuticals and Biotechnology 4.41
Laurus Labs Ltd. 3.18
Glenmark Pharmaceuticals Ltd 1.23
Chemicals and Petrochemicals 4.22
Navin Fluorine International Ltd. 3.19
SOLAR INDUSTRIES INDIA LIMITED 1.03
Fertilizers and Agrochemicals 3.01
UPL Ltd 1.59
Coromandel International Ltd. 1.42
Aerospace and Defense 2.96
Bharat Electronics Ltd. 1.63
BHARAT DYNAMICS LTD 1.33
Retailing 2.37
FSN E-COMMERCE VENTURES LTD. 2.37
Commercial Services and Supplies 1.89
Redington India Ltd 1.89
Financial Technology (Fintech) 1.76
ONE 97 COMMUNICATIONS LTD. 1.76
Agricultural, Commercial and Construction Vehicles 1.72
ASHOK LEYLAND LTD. 1.72
Cigarettes and Tobacco Products 1.66
Godfrey Phillips India Ltd. 1.66
Transport Services 1.39
Inter Globe Aviation Ltd 1.39
Power 1.30
ADANI POWER LTD. 1.30
Beverages 1.20
Radico Khaitan Ltd. 1.20
Telecom - Services 1.17
Bharti Airtel Ltd 1.17
Industrial Manufacturing 0.42
MAZAGOAN DOCK SHIPBUILDERS LTD 0.42
Consumer Durables 0.39
AMBER ENTERPRISES INDIA LTD. 0.39
Equity & Equity related - Total 99.95
Triparty Repo 0.03
Net Current Assets/(Liabilities) 0.02
Grand Total 100.00

Net Asset Value (NAV)
Rs46.5796
(as on January 30, 2026)

Available Plans/Options

The Scheme does not offer any Plans/Options for investment.


Fund Manager* Mr. Devender Singhal
Mr. Satish Dondapati &
Mr. Abhishek Bisen
BenchmarkNIFTY Alpha 50 Index TRI
Allotment dateDecember 22, 2021
AAUMRs721.41 crs
AUMRs714.19 crs
Folio count94,571

Ratios
Portfolio Turnover :196.64%
Tracking Error:0.26%
Minimum Investment Amount

Through Exchange:1 Unit,
Through AMC: Greater than Rs. 25 Crore - For Large Investors***

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil.
Exit Load: Nil.


Total Expense Ratio**
0.30%

Data as on 31st January, 2026 unless otherwise specified.
Folio Count data as on 31st December 2025.

Fund



Benchmark: NIFTY Alpha 50 Index TRI


This product is suitable for investors who are seeking*:
  • Long term capital growth
  • Investment in stocks Comprising the underlying index and endeavours to track the benchmark index, subject to tracking errors.

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com


***Not applicable to Recognised Provident Funds, approved gratuity funds and approved superannuation funds under Income Tax Act, 1961, Schemes managed by Employee Provident Fund Organisation of India and Market Makers as per para 3.6.2.1 and 3.6.2.2 of SEBI Master Circular no. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024 as amended from time to time along with SEBI letter no. SEBI/HO/IMD- POD- 2/P/OW/2024/15311/1 dated April 26, 2024, SEBI letter no. SEBI/HO/IMD- POD-2/P/OW/2024/34080/1 dated October 29, 2024 and SEBI/HO/IMD- POD-2/P/OW/2024/6441/1 dated February 28, 2025 and SEBI/HO/IMD-POD-2/P/OW/2025/22818/1 dated August 26, 2025.
**Total Expense Ratio includes applicable GST.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'